BiowaveHOME Neuromodulation Pain Therapy Device

BiowaveHOME Neuromodulation Pain Therapy Device is an FDA 510(k)-cleared medical device (K152437) manufactured by Biowave Corporation. This device is classified under the Neurology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on September 24, 2015. Regulation: 8.